Stock Quote

Covance Inc (CVD) (NYSE Arca)
As of  23 Nov 2009
53.59USD
Price Change
+0.70
Percent Change
+1.32%
 
$53.59
23 Nov 2009
+1.32%
$53.59
--
274,761
$54.27
$53.29
$58.95
$32.31
1.05
523,409

Research Another Stock: Symbol Look-up
China Biotech Week in Review: CROs Consolidating
Sunday, 22 Nov 2009 08:03am EST(Seeking Alpha) 
How Do You Say 'Drug Development' in Mandarin?
Thursday, 12 Nov 2009 11:18am EST(The Motley Fool) 
Pharma Researchers Need a Cure
Thursday, 29 Oct 2009 11:24am EDT(The Motley Fool) 
Covance Inc. Q3 2009 Earnings Call Transcript
Thursday, 22 Oct 2009 03:19pm EDT(Seeking Alpha) 
5-Star Stocks Poised to Pop: inVentiv Health
Tuesday, 6 Oct 2009 05:48am EDT(The Motley Fool) 
 
Name Current Position Compensation
Herring, Joseph Chairman of the Board, Chief Executive Officer 5,410,530
Klitgaard, William Chief Financial Officer, Corporate Senior Vice President, Treasurer 1,446,520
Barr, Wendel Chief Operating Officer, Executive Vice President 1,765,780

Profile

Covance Inc. is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. The Company also provides laboratory testing services to the chemical,... Full Description

Company Address

Covance Inc
210 Carnegie Center
Princeton   NJ   08540
P: +1609.4524440
F: +1609.4524769

Analyst Research

Performance of Key Competitors

Company Price Change
Charles River Laboratories $32.59 +0.15
MDS Inc. $8.05 -0.12
PAREXEL International Corporation $12.88 +0.33
  CVD Industry
P/E(TTM) 19.07 12.80
P/S(TTM) 1.79 29.90
ROI(TTM) 13.10 2.35
ROE(TTM) 14.11 3.59
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.70
EPS Est. (Current Year) 2.62
Total Revenue $493.72M
Net Income $50.90M
EPS $0.79